Etanercept-induced lichen planus-like eruptions following the lines of blaschko

European Journal of Dermatology

Volumn 22, Issue 4, 2012, Pages 544-545

  Utsu, Momoko ^a   Hida, Tokimasa ^a   Takahashi, Hiroki ^a   Yamashita, Toshiharu ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; PREDNISOLONE;

ADULT; CASE REPORT; CLINICAL FEATURE; DERMATITIS; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HUMAN; LETTER; LICHEN PLANUS; RASH; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME;

ANTIRHEUMATIC AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; LICHEN PLANUS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 84865385158     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1747     Document Type: Letter

References (6)

1. Asarch A, Gottlieb AB, Lee J, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor- α antagonists. J Am Acad Dermatol 2009; 61: 104-11.
2. Seneschal J, Milpied B, Vergier B, et al. Cytokine imbalance with increased production of interferon- _ in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009; 161: 1081-8.
3. Iki S, Yokota S, Okabayashi T, et al. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. Virology 2005; 343: 106-15.
4. Fiorentino DF. The Yin and Yang of TNF- α inhibition. Arch Dermatol 2007; 143: 233-6.
5. Battistella M, Rivet J, Bachelez H, et al. Lichen planus associated with etanercept. Br J Dermatol 2008; 158: 188-90.
6. Wenzel J, Scheler M, Proelss J, et al. Type I interferon-associated cytotoxic inflammation in lichen planus. J Cutan Pathol 2006; 33: 672-8.